24 August 2020 in Archives of Endocrinology and Metabolism
Objective: The objective of this study is to study association between testosterone and diabetes in Kashmiri males. Subjects and methods: A total of 300 males with Type 2 diabetes visited an outpatient and inpatient clinic at Shri Maharaja Had Singh (SMHS) hospital, Srinagar, J&K India. The blood sugar and HbA1c, which are the markers of diabetes, and serum testosterone levels were measured.The blood samples from both the cases and controls were collected. Results: Out of 300 subjects, 42% had a testosterone deficiency. A relationship between type 2 diabetic males and healthy males was observed, and testosterone levels were determined to be significantly lower among diabetic males (p < 0.001) when compared to healthy males. Then, we compared diabetic markers among testosterone deficient and normal testosterone level groups; the mean fasting plasma glucose (p = 0.0019) and glycated haemoglobin (HbA1c; p = 0.0449) levels were significantly higher in the testosterone deficient group than in the control group. To elucidate the relationship between the serum total testosterone level and fasting plasma glucose and HbA1c values, Pearson's correlation test was performed. Fasting plasma glucose levels (r = -0.252, p = 0.001) and HbA1c values (r = -0.697, p = 0.001) showed a significant negative correlation with serum testosterone levels among diabetic males. Conclusions: This study shows that diabetes causes low testosterone levels among males, and lower testosterone levels can act as a marker for diabetes. Thus, with timely intervention, mortality and co-morbidity associated with diabetes can be prevented.
1 January 2026 in Endocrine Oncology
Context: Somatotrophinomas can occasionally occur in familial settings and may be associated with known germline mutations, such as MEN1, AIP, CDKN1B, PRKAR1A, SDHx, and MAX. Recently, the CHEK2 gene has emerged as a potential pituitary tumour predisposition gene. Objective: To present a rare case of a patient with a pituitary somatotrophinoma and primary hyperparathyroidism (PHPT) associated with a likely pathogenic CHEK2 germline mutation, suggesting a novel MEN1-like phenotype. Methods: We conducted a detailed clinical, biochemical, radiological, and genetic evaluation of a 38-year-old woman presenting with features of acromegaly and PHPT. Genetic testing for known MEN1 syndrome-associated genes and broader pituitary tumour predisposition genes was performed. Results: The patient presented with features of acromegaly of 3 years duration and a collagenoma. Laboratory evaluation revealed an elevated IGF-1. Biochemical and imaging studies also revealed PTH-dependent hypercalcaemia and bilateral inferior parathyroid adenomas. Genetic testing for a panel of genes causing hypercalcaemia – including MEN1 and CDKN1B – was negative; however, a pathogenic nonsense variant in CHEK2 (c.232C>T; p.(Gln78Ter); gnomAD frequency: 0.0006%) was detected with exome sequencing. The patient underwent transsphenoidal resection of the pituitary tumour followed by gamma-knife radiosurgery and received long-acting octreotide every four weeks. Parathyroidectomy was performed 1.5 years later. Conclusion: This is the first reported case of a CHEK2 germline mutation associated with somatotrophinoma, PHPT, and collagenoma, mimicking the clinical MEN1 syndrome. These findings expand the spectrum of possible CHEK2-associated neoplasia and highlight the need to consider CHEK2 as a possible candidate gene in patients with MEN1-like syndromes when common mutations have been excluded.
7 January 2026 in Endocrinology Research and Practice
Primary hyperparathyroidism (PHPT) and antiphospholipid syndrome (APS) are distinct disorders, with their coexistence being exceptionally rare. The case of a 37-year-old male diagnosed with PHPT who was also found to have external jugular vein thrombosis is described. On evaluation, the patient was diagnosed with primary APS, complicated by pulmonary arterial hypertension and interstitial lung disease. The patient underwent successful parathyroidectomy, leading to normalization of calcium and parathyroid hormone levels, while anticoagulation with rivaroxaban was initiated for APSrelated thrombosis. Though severe hypercalcemia is known to be associated with thrombosis, this patient had mild hypercalcemia and primary APS-related thrombosis, which is exceptionally rare. Cite this article as: Alam E, Jasti P, Bhat MH, Baba MS, Hamdani ZF, Dutta P. Primary hyperparathyroidism associated with primary antiphospholipid syndrome and pulmonary involvement. Endocrinol Res Pract. 2026;30(1):68-71.